Leveraging this integrative understanding, bridging developmental neurobiology, incretin pharmacology, and neuromodulation, will be key to achieving durable metabolic restoration in obesity and diabetes. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.